|
1
|
Zanger UM, Turpeinen M, Klein K and Schwab M: Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation. Anal Bioanal Chem. 392:1093–1108. 2008.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Pelkonen O, Turpeinen M, Hakkola J, Honkakoski P, Hukkanen J and Raunio H: Inhibition and induction of human cytochrome P450 enzymes: Current status. Arch Toxicol. 82:667–715. 2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wolf CR, Mahmood A, Henderson CJ, McLeod R, Manson MM, Neal GE and Hayes JD: Modulation of the cytochrome P450 system as a mechanism of chemoprotection. IARC Sci Publ. 139:165–173. 1996.PubMed/NCBI
|
|
4
|
Kress S and Greenlee WF: Cell-specific regulation of human CYP1A1 and CYP1B1 genes. Cancer Res. 57:1264–1269. 1997.PubMed/NCBI
|
|
5
|
Krusekopf S, Roots I, Hildebrandt AG and Kleeberg U: Time-dependent transcriptional induction of CYP1A1, CYP1A2 and CYP1B1 mRNAs by H+/K+ -ATPase inhibitors and other xenobiotics. Xenobiotica. 33:107–118. 2003.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Fujii-Kuriyama Y and Mimura J: Molecular mechanisms of AhR functions in the regulation of cytochrome P450 genes. Biochem Biophys Res Commun. 338:311–317. 2005.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lund AH and van Lohuizen M: Epigenetics and cancer. Genes Dev. 18:2315–2335. 2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
University of California: Santa Cruz Genomics Institute. UCSC Genome Browser. Available from: http://genome.ucsc.edu/index.html.
|
|
9
|
Ivanov M, Kacevska M and Ingelman-Sundberg M: Epigenomics and interindividual differences in drug response. Clin Pharmacol Ther. 92:727–736. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Fisel P, Schaeffeler E and Schwab M: DNA methylation of ADME genes. Clin Pharmacol Ther. 99:512–527. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Beedanagari SR, Taylor RT, Bui P, Wang F, Nickerson DW and Hankinson O: Role of epigenetic mechanisms in differential regulation of the dioxin-inducible human CYP1A1 and CYP1B1 genes. Mol Pharmacol. 78:608–616. 2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Nakajima M, Iwanari M and Yokoi T: Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYP1 family in MCF-7 and HeLa cells. Toxicol Lett. 144:247–256. 2003.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yao EF and Denison MS: DNA sequence determinants for binding of transformed Ah receptor to a dioxin-responsive enhancer. Biochemistry. 31:5060–5067. 1992.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Swanson HI, Tullis K and Denison MS: Binding of transformed Ah receptor complex to a dioxin responsive transcriptional enhancer: Evidence for two distinct heteromeric DNA-binding forms. Biochemistry. 32:12841–12849. 1993.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Skene PJ and Henikoff S: An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites. eLife. 6(e21856)2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Nishimura M, Ueda N and Naito S: Effects of dimethyl sulfoxide on the gene induction of cytochrome P450 isoforms, UGT-dependent glucuronosyl transferase isoforms, and ABCB1 in primary culture of human hepatocytes. Biol Pharm Bull. 26:1052–1056. 2003.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Habano W, Gamo T, Sugai T, Otsuka K, Wakabayashi G and Ozawa S: CYP1B1, but not CYP1A1, is downregulated by promoter methylation in colorectal cancers. Int J Oncol. 34:1085–1091. 2009.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tsuchiya Y, Nakajima M and Yokoi T: Critical enhancer region to which AhR/ARNT and Sp1 bind in the human CYP1B1 gene. J Biochem. 133:583–592. 2003.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sambrook J and Russell DW: Isolation of high-molecular-weight DNA from mammalian cells using proteinase K and phenol. In: Molecular Cloning: A Laboratory Manual. 3rd edition. Cold Spring Harbor Laboratory Press, New York, NY, pp6.4-6.12, 2001.
|
|
20
|
Xiong Z and Laird PW: COBRA: A sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 25:2532–2534. 1997.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Warnecke PM, Stirzaker C, Song J, Grunau C, Melki JR and Clark SJ: Identification and resolution of artifacts in bisulfite sequencing. Methods. 27:101–107. 2002.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Habano W, Gamo T, Terashima J, Sugai T, Otsuka K, Wakabayashi G and Ozawa S: Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells. BMC Cancer. 11(81)2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Shehin SE, Stephenson RO and Greenlee WF: Transcriptional regulation of the human CYP1B1 gene. Evidence for involvement of an aryl hydrocarbon receptor response element in constitutive expression. J Biol Chem. 275:6770–6776. 2000.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Tang YM, Wo YY, Stewart J, Hawkins AL, Griffin CA, Sutter TR and Greenlee WF: Isolation and characterization of the human cytochrome P450 CYP1B1 gene. J Biol Chem. 271:28324–28330. 1996.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Shen ES and Whitlock JP Jr: The potential role of DNA methylation in the response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Biol Chem. 264:17754–17758. 1989.PubMed/NCBI
|
|
26
|
Takahashi Y, Suzuki C and Kamataki T: Silencing of CYP1A1 expression in rabbits by DNA methylation. Biochem Biophys Res Commun. 247:383–386. 1998.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wolffe AP: Transcriptional control: Imprinting insulation. Curr Biol. 10:R463–R465. 2000.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Siegfried Z and Cedar H: DNA methylation: A molecular lock. Curr Biol. 7:R305–R307. 1997.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Chang H, Chang LW, Cheng YH, Tsai WT, Tsai MX and Lin P: Preferential induction of CYP1A1 and CYP1B1 in CCSP-positive cells. Toxicol Sci. 89:205–213. 2006.PubMed/NCBI View Article : Google Scholar
|
